Commercialization of nanotechnology

December 06, 2007

Nanotechnology Victoria (NanoVic) and AZoNetwork are pleased to release the third in a series of Nanotechnology Reviews in a Podcast format.

This third Podcast titled "Commercialization of Nanotechnology" features key stakeholders discussing the crucial issues around how nanotechnology can be taken from research and development and translated into successful commercial outcomes.

Dr Peter Binks, CEO of NanoVic (Melbourne) and podcast interviewee commented, "Nanotechnology has moved from the research laboratory into the domain of product development over the last two years. It is now an investment proposition, and faces the challenges of any new venture in an uncertain market.

This podcast is very timely. Five of the investment managers, advisors and portfolio managers give their candid views on what nanotechnology investments are like, and what features successful investments must have. This provides a useful perspective for anyone considering investment in this new field, or sponsoring a development trying to make its way in the market"

Dr Ian Birkby, the CEO of AZoNetwork (Sydney), the operator of the AZoNano.com website commented, "The commercialization of nanotechnology provides real opportunities but there are questions as to whether nanotechnology requires a different model. This podcast gives people considering commercialization real insights into different approaches and advice from players who are in different stages of the nanotechnology investment cycle."

The podcast features interviews with:Click here to listen to the podcast in full
-end-
About AZoNetwork

AZoNetwork owns and operates The A to Z of Building, The A to Z of Materials, The A to Z of Nanotechnology, and the A to Z of medical news.

Based in Sydney Australia the company was founded in April 2000 and currently serves over 2.4 million monthly visitors sessions from the engineering, science, construction and medical sectors.

About Nanotechnology Victoria ( NanoVic)

Nanotechnology Victoria Ltd (Melbourne Australia) is a nanotechnology commercialization company with funding from the Victorian Government and contributions from RMIT, Swinburne University and Monash University. It has a portfolio of investments and licenses in nanomaterials and bionano developments, and is a leading contributor to education and public awareness of nanotechnology in Australia

For further information on the podcast please contact:

Dr. Kristin Alford
Director
Bridge8 Pty Ltd (for Nanotechnology Victoria)
PH: +61 410 442 629
Email (kristin@bridge8.com.au)

Dr Ian Birkby
CEO
AZoNetwork
PH: +61 2 9999 0070
Email (ianbirkby@azonetwork.com)

AZoNetwork

Related Nanotechnology Articles from Brightsurf:

Hiring antibodies as nanotechnology builders
Researchers at the University of Rome Tor Vergata recruit antibodies as molecular builders to assemble nanoscale structures made of synthetic DNA.

Nanotechnology delivers hepatitis B vaccine
X-ray imaging shows that nanostructured silica acts as a protective vehicle to deliver intact antigen to the intestine so that it can trigger an immune response.

Want in on nanotechnology? Capitalize on collaborative environments
Patent law experts demonstrate that private-public partnerships lead to promising innovation output measured in patents.

Nanotechnology makes it possible for mice to see in infrared
Mice with vision enhanced by nanotechnology were able to see infrared light as well as visible light, reports a study published Feb.

Healing kidneys with nanotechnology
In new research appearing in the journal Nature Biomedical Engineering, Hao Yan and his colleagues at the University of Wisconsin-Madison and in China describe a new method for treating and preventing Acute Kidney Injury.

A treasure trove for nanotechnology experts
A team from EPFL and NCCR Marvel has identified more than 1,000 materials with a particularly interesting 2-D structure.

Nanotechnology could redefine oral surgery
A trip to the dentist or orthodontist usually instills a sense of dread in most patients, and that's before the exam even begins.

MEDLINE indexes Pharmaceutical Nanotechnology
Pharmaceutical Nanotechnology, an important journal published by Benthm Science, is accepted to be included in MEDLINE.

Nanotechnology and nanopore sequencing
DNA is the hereditary material in our cells and contains the instructions for them to live, behave, grow, and develop.

Nanotechnology: Lighting up ultrathin films
Based on a study of the optical properties of novel ultrathin semiconductors, researchers of Ludwig-Maximilians-Universitaet in Munich have developed a method for rapid and efficient characterization of these materials.

Read More: Nanotechnology News and Nanotechnology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.